Creating effective mRNA vaccines using lipid nanoparticles
Manufacturing and Characterization of Potent mRNA Lipid Nanoparticle Vaccines at Multiple Scales
['FUNDING_R01'] · GEORGE MASON UNIVERSITY · NIH-10694890
This study is working on making mRNA vaccines, like those for Covid-19, even better by figuring out how to improve the tiny particles that carry the vaccine into your cells, so they stay strong and effective for longer.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEORGE MASON UNIVERSITY (nih funded) |
| Locations | 1 site (FAIRFAX, UNITED STATES) |
| Trial ID | NIH-10694890 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the manufacturing and effectiveness of mRNA vaccines, which have shown promise in protecting against infectious diseases like Covid-19. The team is investigating how to optimize the lipid nanoparticles that deliver mRNA to cells, ensuring that the vaccines are both potent and stable. They aim to understand the critical features of the manufacturing process, the impact of truncated mRNA transcripts, and the factors that lead to degradation of the mRNA during production and storage. By addressing these challenges, the research seeks to enhance the overall efficacy of mRNA vaccines.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals interested in participating in clinical trials for new mRNA vaccines targeting infectious diseases.
Not a fit: Patients who are not interested in vaccination or who have contraindications to mRNA vaccines may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and stable mRNA vaccines for various infectious diseases, improving patient protection.
How similar studies have performed: Other research has successfully demonstrated the efficacy of mRNA vaccines, indicating that this approach has the potential for significant advancements in vaccine technology.
Where this research is happening
FAIRFAX, UNITED STATES
- GEORGE MASON UNIVERSITY — FAIRFAX, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PAIGE, MIKELL — GEORGE MASON UNIVERSITY
- Study coordinator: PAIGE, MIKELL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.